Glossary:TAG-00027-Inc-son

Glossary > Incapacitated subject

Incapacitated subject
Tag-ID	TAG-00027-Inc-son
English	Incapacitated subject / Incapacitated person / Subject unable to consent
French	Participant incapable / Personne incapable / Personne dans l'incapacité de consentir
German	Nicht einwilligungsfähige Person / Einwilligungsunfähige Person

References

	Scope	Document part	Language	Document
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40b Absatz 1	HM	§ 40b Absatz 1	DE	DEU AMG - Arzneimittelgesetz 19-Jul-2023
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40b Absatz 2	HM	§ 40b Absatz 2	DE	DEU AMG - Arzneimittelgesetz 19-Jul-2023
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40b Absatz 4	HM	§ 40b Absatz 4	DE	DEU AMG - Arzneimittelgesetz 19-Jul-2023
DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 28 Absatz 3	MD	§ 28 Absatz 3	DE	DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022
EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 64	MD	Article 64	EN	EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 31 Paragraph 1	HM	Article 31 Paragraph 1	EN	EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 31 Paragraph 2-3	HM	Article 31 Paragraph 2-3	EN	EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 35 Paragraph 2-3	HM	Article 35 Paragraph 2-3	EN	EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (7) - (10)	HM	Article 15 (7) - (10)	EN	GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 3-001	HM	Schedule 1 Part 3	EN	GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 3-002	HM	Schedule 1 Part 3	EN	GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 5	HM	Schedule 1 Part 5	EN	GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
WMA Declaration of Helsinki 2024 Paragraph 29 – 30	G	Paragraph 29 – 30	EN	WMA Declaration of Helsinki 2024